Topiramate for Binge Eating Disorder Among Adolescents
Open-Label Study of Topiramate for Binge Eating Disorder and Bulimia Nervosa Among Adolescents
1 other identifier
interventional
N/A
1 country
1
Brief Summary
This is a study of topiramate to see whether topiramate decreases binge eating behavior among adolescents and young adults. The investigators did also checked whether topiramate affected cognitive function or not.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2003
CompletedFirst Submitted
Initial submission to the registry
October 7, 2008
CompletedFirst Posted
Study publicly available on registry
October 8, 2008
CompletedOctober 8, 2008
September 1, 2008
October 7, 2008
October 7, 2008
Conditions
Keywords
Interventions
Eligibility Criteria
You may qualify if:
- Subjects (aged 12 to 23) were included if they
- Met the criteria of bulimia nervosa or eating disorder NOS with binge-eating behavior in DSM-IV-TR,
- Had weight \> or = 100th % of expected body weight for their age,
- Engaged in binge eating at least once a week for 9 out of the 12 weeks prior to the study entry, and
- Were judged by a clinician to be stable enough to be treated for their psychiatric condition as an outpatient (i.e, no acute suicidality, hallucination, unstable vital signs or persistently abnormal laboratory results due to eating disorder).
You may not qualify if:
- Subjects whose psychotropic medications had been changed within 4 weeks prior to the entry or who had started psychotherapy within 3 months prior to the entry were excluded.
- Subjects were also excluded if they were taking carbonic anhydrase inhibitors, carbamazepine, phenytoin, phenobarbital, valproic acid, evening primrose oil or oral contraceptives.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Zucker Hillside Hospital
Glen Oaks, New York, 11004, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
October 7, 2008
First Posted
October 8, 2008
Study Start
July 1, 2003
Last Updated
October 8, 2008
Record last verified: 2008-09